← Back to Clinical Trials
Recruiting NCT06787235

NCT06787235 Nutritional Intervention to Reduce Alcohol Consumption

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06787235
Status Recruiting
Phase
Sponsor University of Bern
Condition Alcohol Use Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-04-01
Primary Completion 2026-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Modified ketogenic dietIndividual nutritional consultation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-04-01 with a primary completion date of 2026-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To test whether the implementation of a modified ketogenic diet (KD) is efficient in reducing outcome measures in relation to alcohol consumption in patients with alcohol use disorder (AUD).

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 * AUD diagnosis according to Diagnostic and Statistical Manual (DSM)-5 * BMI \> 22 (because of potential modified KD-side effect of weight loss) * Able to give informed consent as documented by signature * Last alcohol drink intake within 72 hours before treatment initiation Exclusion Criteria: * Pregnant or lactating women, * Inability or contraindications to undergo the investigated intervention (BMI\<18) * Clinically significant concomitant diseases impairing reasonable decision making (e.g. psychosis, dementia) * Inability to follow the procedures of the study, e.g. due to language problems, Previous enrolment in a clinical trial * Patients undergoing opioid maintenance treatment * Patients taking medications for drinking relapse prevention * Patients with a blood hemoglobin A1C (HbA1C) \> 7%

Contact & Investigator

Central Contact

Philippe Pfeifer, MD

✉ philippe.pfeifer@upd.ch

📞 +41586309252

Principal Investigator

Philippe Pfeifer

STUDY CHAIR

University of Bern

Frequently Asked Questions

Who can join the NCT06787235 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Alcohol Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06787235 currently recruiting?

Yes, NCT06787235 is actively recruiting participants. Contact the research team at philippe.pfeifer@upd.ch for enrollment information.

Where is the NCT06787235 trial being conducted?

This trial is being conducted at Bern, Switzerland.

Who is sponsoring the NCT06787235 clinical trial?

NCT06787235 is sponsored by University of Bern. The principal investigator is Philippe Pfeifer at University of Bern. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology